Gynecologic Oncology
RSSArticles
-
Pregnancy Temporarily Increases Breast Cancer Risk: Parallels to Hormonal Contraception?
In a pooled analysis of prospective studies, researchers found an increased risk of breast cancer among parous women that persists for more than 20 years after childbirth. Breastfeeding did not modify this pattern.
-
Intrauterine Devices and Cervical Cancer
In this case-control study, levonorgestrel IUD use was associated with a slightly increased rate of CIN 2 but not CIN 3. Copper IUD use was not associated with CIN 2 or CIN 3.
-
Primary HPV Screening: Ready for Prime Time?
In this randomized, controlled trial of more than 25,000 women, participants with negative high-risk human papillomavirus testing at baseline had rates of CIN 3+ at 48 months that were lower compared to negative liquid-based cytology testing.
-
USPSTF Recommendation: Screening for Cervical Cancer
The U.S. Preventive Services Task Force (USPSTF) recently updated its recommendations for cervical cancer screening. Practitioners currently following guidelines published by ASCCP (and supported by ACOG) will not find any discrepancies in the new USPSTF position
-
The Risk of Malignancy in Hysterectomy
There has been significant publicity about the risk of malignancy associated with morcellation in hysterectomy, but in reality the incidence is quite low.
-
The Latest in Genetic Screening for Gynecologic Malignancies
Genetic testing is changing rapidly. With the advent of more sophisticated genetic mutation panels, it is important that providers of women’s healthcare consider appropriate referral and testing for those women at increased risk of malignancy.
-
Breast Cancer and Hormonal Contraception: New Information or Sensationalism?
Highly publicized results from the Danish database demonstrate an increase in the risk of breast cancer associated with current use of hormonal contraception. Consistent with prior research, the risk is small, confined to current users, and disappears following discontinuation.
-
Is Bariatric Surgery the Antidote for Female-associated Cancers?
This study investigated gastric surgery as a prevention for female-associated cancers. Women with a body mass index of ≥ 38 kg/m2 who had surgery had an average of 28 kg of weight loss compared to the control group. This resulted in a statistically significant decrease in endometrial cancer.
-
Obesity: The New Epidemic
Obesity has risen significantly worldwide and is associated with an increased risk of morbidity and mortality in women throughout their lives. Risks include infertility, gestational diabetes, type 2 diabetes, heart disease, and cancer.
-
Obesity and Endometrial Cancer
Obesity is a major risk factor for endometrial cancer as well as for other major comorbidities.